Login / Signup
Update to "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors".
Mojun Zhu
Tanios Bekaii-Saab
Published in:
The oncologist (2022)
Keyphrases
</>
neuroendocrine tumors
dna repair
dna damage
oxidative stress
binding protein